• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Adagene

Professional kite surfer soars through the air
Biotech

Merck KGaA lands new R&D chief—Chutes & Ladders

Merck KGaA lands new R&D chief. Cartography maps expanded leadership team. Psychedelic CEO steps down.
Darren Incorvaia , Zoey Becker Sep 5, 2025 8:30am
graphic art of a right hand signing something

Sanofi takes up option on Adagene bispecific, invests $25M

Jul 1, 2025 8:10am
eraser pencil mistake write cut pen scrub out

ADC Therapeutics calls it quits on Adagene solid tumor collab

Aug 31, 2023 10:24am
Monoclonal Antibody GettyImages

Sanofi looks for a 'safe' bet in $2.5B tie up for Adagene tech

Mar 2, 2022 6:00am
nasdaq

Adagene plans $125M IPO to challenge BMS and Pfizer

Jan 20, 2021 9:00am
money

China's Adagene bags $69M to advance lead immunotherapies

Jan 8, 2020 7:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings